Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Gingival Depigmentation With Diode and Er,Cr:YSGG Laser: A Split-mouth Trial

NCT: NCT07520266 · COMPLETED

NCT IDNCT07520266
StatusCOMPLETED
Start Date2023-03-01
Completion2025-05-01

Brief Summary

Gingival hyperpigmentation is a common physiological condition caused by excessive melanin deposition in oral mucosa, negatively affecting smile esthetics. Laser therapy has become an effective treatment option due to advantages such as minimal bleeding, reduced postoperative discomfort, and faster healing. This clinical study aims to evaluate clinical characteristics of gingival pigmentation and compare treatment outcomes between diode laser and Er,Cr:YSGG laser techniques. Outcomes include pigmentation reduction, postoperative pain, wound healing, bleeding, patient satisfaction, and recurrence rate.

Frequently Asked Questions

What is Gingival Depigmentation With Diode and Er,Cr:YSGG Laser: A Split-mouth Trial?

Gingival Depigmentation With Diode and Er,Cr:YSGG Laser: A Split-mouth Trial is a clinical trial registered under NCT07520266. Current status: COMPLETED.

What is the status of NCT07520266?

The current status of NCT07520266 (Gingival Depigmentation With Diode and Er,Cr:YSGG Laser: A Split-mouth Trial) is: COMPLETED.

When did Gingival Depigmentation With Diode and Er,Cr:YSGG Laser: A Split-mouth Trial start?

Gingival Depigmentation With Diode and Er,Cr:YSGG Laser: A Split-mouth Trial started on 2023-03-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.